American Century Companies Inc. grew its stake in SelectQuote, Inc. (NYSE:SLQT - Free Report) by 41.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 312,000 shares of the company's stock after buying an additional 91,497 shares during the period. American Century Companies Inc. owned approximately 0.18% of SelectQuote worth $1,161,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. lifted its position in shares of SelectQuote by 4.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,181,663 shares of the company's stock worth $2,564,000 after purchasing an additional 53,159 shares during the period. State Street Corp boosted its position in shares of SelectQuote by 0.7% during the third quarter. State Street Corp now owns 2,894,067 shares of the company's stock valued at $6,280,000 after purchasing an additional 21,413 shares in the last quarter. Barclays PLC raised its holdings in SelectQuote by 166.8% in the third quarter. Barclays PLC now owns 198,357 shares of the company's stock worth $430,000 after purchasing an additional 124,005 shares in the last quarter. Geode Capital Management LLC lifted its position in SelectQuote by 1.4% during the third quarter. Geode Capital Management LLC now owns 3,081,391 shares of the company's stock valued at $6,688,000 after buying an additional 43,197 shares during the period. Finally, Virtu Financial LLC purchased a new stake in shares of SelectQuote in the 3rd quarter worth about $150,000. Institutional investors own 34.59% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Noble Financial raised shares of SelectQuote to a "strong-buy" rating in a research report on Wednesday, February 12th.
Read Our Latest Research Report on SelectQuote
Insider Activity
In other news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $5.44, for a total transaction of $272,000.00. Following the sale, the insider now owns 1,166 shares of the company's stock, valued at approximately $6,343.04. This represents a 97.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 11.40% of the company's stock.
SelectQuote Trading Up 0.9 %
SelectQuote stock traded up $0.03 during midday trading on Wednesday, reaching $3.15. The stock had a trading volume of 187,252 shares, compared to its average volume of 1,856,390. The company has a fifty day moving average of $4.04 and a 200 day moving average of $3.38. The company has a quick ratio of 6.36, a current ratio of 6.36 and a debt-to-equity ratio of 2.10. SelectQuote, Inc. has a 52-week low of $1.48 and a 52-week high of $6.86. The firm has a market cap of $542.08 million, a price-to-earnings ratio of -35.20 and a beta of 1.25.
SelectQuote (NYSE:SLQT - Get Free Report) last issued its quarterly earnings results on Monday, February 10th. The company reported $0.30 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.21. SelectQuote had a negative return on equity of 4.38% and a negative net margin of 0.95%. On average, analysts anticipate that SelectQuote, Inc. will post -0.07 earnings per share for the current fiscal year.
SelectQuote Company Profile
(
Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Articles

Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.